Kisqali 400 MG daily dose 42S
Ended Awarded Last action
- Contract number
- SPE2DR26FXQ5M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,139
Award facts
- Contract value 100% obligated
- $18,138.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,138.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for 42 units of Kisqali 400 mg daily dose tablets. The order, issued on December 3, 2025, with an ultimate completion date of December 24, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vehicle designated SPE2DX and running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Kisqali, a ribociclib-based breast cancer treatment medication, is a specialty pharmaceutical product critical to Defense Health Agency and military healthcare operations. AmerisourceBergen Drug Corp maintains a significant federal contract portfolio as a major pharmaceutical distributor serving the military healthcare supply chain, with demonstrated capability to fulfill federal procurement requirements for both brand-name specialty medications and generic drugs across multiple therapeutic domains. The delivery order reflects the company's ongoing role as a primary supplier of oncology and other specialized medications supporting military beneficiary populations.
Quick answers
Who was awarded contract SPE2DR26FXQ5M?
SPE2DR26FXQ5M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FXQ5M worth?
The government has obligated $18,139 on SPE2DR26FXQ5M.
Is contract SPE2DR26FXQ5M an order under another contract?
Yes. SPE2DR26FXQ5M is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXQ5M competed?
The extent of competition for SPE2DR26FXQ5M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award